companydata.dkcompanydata.dk

ZEALAND PHARMA A/S: Financial statements 2015

CVR: 20045078

Source: annual report 2015, Danish Business Authority

01/01/2015 – 31/12/2015

ZEALAND PHARMA A/S (CVR 20045078) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 187,677,000 and a net result of DKK -113,957,000 compared with DKK -64,990,000 the year before. That is an increase of 22% compared with the year before. The profit margin was -60.7%. Equity in the 2015 report amounted to DKK 252,231,000. The solvency ratio was 39.7%.

Revenue
DKK 187,677,000
Gross Profit
DKK 165,410,000
Profit/Loss
DKK -113,957,000
Equity
DKK 252,231,000
Total Assets
DKK 634,688,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015187.7M165.4M-114M252.2M-
2014153.8M140M-65M252.8M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ZEALAND PHARMA A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2015

ZEALAND PHARMA A/S publishes interim reportDec 9, 2015

ZEALAND PHARMA A/S has published its interim report for the period January 1, 2015 to September 30, 2015.

ZEALAND PHARMA A/S publishes interim reportAug 28, 2015

ZEALAND PHARMA A/S has published its interim report for the period April 1, 2015 to June 30, 2015.

ZEALAND PHARMA A/S publishes interim reportJun 1, 2015

ZEALAND PHARMA A/S has published its interim report for the period January 1, 2015 to March 31, 2015.

ZEALAND PHARMA A/S: The 2014 annual report is outApr 26, 2015

ZEALAND PHARMA A/S has published its annual report for 2014. Revenue came to DKK 153,773,000, and the net result was DKK -64,990,000.

Alf Gunnar Martin Nicklasson joins the board of ZEALAND PHARMA A/SApr 21, 2015

As of April 21, 2015, Alf Gunnar Martin Nicklasson has joined the board of directors of ZEALAND PHARMA A/S.

Rosemary Crane joins the board of ZEALAND PHARMA A/SApr 21, 2015

As of April 21, 2015, Rosemary Crane has joined the board of directors of ZEALAND PHARMA A/S.

Catherine Moukheibir joins the board of ZEALAND PHARMA A/SApr 21, 2015

As of April 21, 2015, Catherine Moukheibir has joined the board of directors of ZEALAND PHARMA A/S.

Jørgen Lindegaard leaves the board of ZEALAND PHARMA A/SApr 21, 2015

As of April 21, 2015, Jørgen Lindegaard has left the board of directors of ZEALAND PHARMA A/S.

Daniël Jan Ellens leaves the board of ZEALAND PHARMA A/SApr 21, 2015

As of April 21, 2015, Daniël Jan Ellens has left the board of directors of ZEALAND PHARMA A/S.

Florian Nicolas Christian Reinaud leaves the board of ZEALAND PHARMA A/SFeb 2, 2015

As of February 2, 2015, Florian Nicolas Christian Reinaud has left the board of directors of ZEALAND PHARMA A/S.

About ZEALAND PHARMA A/S

ZEALAND PHARMA A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1997. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ZEALAND PHARMACEUTICALS A/S and PEPTIDE PROBE TECHNOLOGIES ApS. The management consists of Adam Sinding Steensberg and Henriette Wennicke. The board consists of Alf Gunnar Martin Nicklasson (chair), Kirsten Aarup Drejer, Adam Krisko Nygaard and Anneline Nansen. The company's owners include ZEALAND PHARMA A/S, Van Herk Investments B.V. and Van Herk Management Services B.V.. The company has 575 employees (2026). In 2025, the company reported revenue of DKK 9,214,860,000 and a net result of DKK 6,455,008,000 compared with DKK -1,078,828,000 the year before. Equity in the 2025 report amounted to DKK 14,830,613,000.

Source: annual report 2025, Danish Business Authority